ROIVANT SCIENCES LTD. Increase (Decrease) in Other Operating Liabilities
ROIVANT SCIENCES LTD. (ROIV) reported Increase (Decrease) in Other Operating Liabilities of $7.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-06
- ROIVANT SCIENCES LTD. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $7.93M, a 35.21% increase year-over-year.
- ROIVANT SCIENCES LTD. increase (decrease) in other operating liabilities for the quarter ending 2025-06-30 was $5.87M.
- ROIVANT SCIENCES LTD. increase (decrease) in other operating liabilities for fiscal 2026 was -$1.01M, a 230.40% decline from fiscal 2025.
- ROIVANT SCIENCES LTD. increase (decrease) in other operating liabilities for fiscal 2025 was $773.00K.
- ROIVANT SCIENCES LTD. increase (decrease) in other operating liabilities for fiscal 2024 was -$2.39M, a 211.07% decline from fiscal 2023.
- ROIVANT SCIENCES LTD. increase (decrease) in other operating liabilities for fiscal 2023 was $2.15M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|
| 2026-06-30 | $7.93M 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$1.01M 10-K · filed 2026-05-20 | ||
| 2025-06-30 | $5.87M 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $773.00K 10-K · filed 2026-05-20 | -$9.28M 10-K · filed 2025-05-29 | |
| 2024-03-31 | -$2.39M 10-K · filed 2026-05-20 | $7.54M 10-K · filed 2024-05-30 | |
| 2023-03-31 | $2.15M 10-K · filed 2025-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |